Analysts Set Lam Research Corporation (NASDAQ:LRCX) Price Target at $244.88

Lam Research Corporation (NASDAQ:LRCX) has earned a consensus rating of “Moderate Buy” from the thirty-five brokerages that are presently covering the firm, Marketbeat.com reports. Six analysts have rated the stock with a hold recommendation, twenty-eight have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $244.8813.

A number of research analysts have recently commented on the company. Sanford C. Bernstein upped their target price on Lam Research from $275.00 to $285.00 and gave the company an “outperform” rating in a research note on Monday, February 9th. Argus upped their price objective on Lam Research from $175.00 to $280.00 in a research report on Tuesday, February 3rd. JPMorgan Chase & Co. lifted their target price on Lam Research from $165.00 to $300.00 and gave the stock an “overweight” rating in a research report on Thursday, January 29th. Barclays set a $250.00 target price on shares of Lam Research in a research note on Thursday, January 29th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and issued a $200.00 price target (up previously from $175.00) on shares of Lam Research in a research note on Monday, December 15th.

More Lam Research News

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: TD Cowen raised its price target sharply to $290 (from $170) and kept a Buy rating, highlighting the large 2026 WFE market opportunity that benefits Lam. Is Lam Research (LRCX) One of the Best Growth Stocks to Buy for the Next 20 Years?
• Positive Sentiment: BofA’s Vivek Arya named Lam his top semiconductor-equipment pick, citing a projected ~$135B industry spending surge in 2026 as AI demand forces multi-year factory investment — a direct tailwind for Lam’s tools. Lam Research Named Top Semiconductor Pick As AI-Driven Manufacturing Supercycle Shifts Into High Gear
• Positive Sentiment: Lam’s Boise expansion strengthens its operational ties with Micron and positions the company to capture increased demand for AI memory production equipment. This local expansion is being read as evidence of customers ramping capacity. Lam Research Boise Expansion Deepens Micron Ties In AI Memory Cycle
• Positive Sentiment: Multiple bullish write-ups argue Lam has durable growth attributes that could drive strong multi-year returns, reinforcing investor conviction around the AI/memory-driven cycle. 3 Reasons Growth Investors Will Love Lam Research (LRCX) 3 Reasons Growth Investors Will Love Lam Research (LRCX) Is Lam Research (LRCX) One of the Best Growth Stocks to Buy for the Next 20 Years?
• Neutral Sentiment: A report about Japan’s Toto (a supplier to chip-equipment makers) and activist interest may signal broader supply?chain positioning for chip-equipment suppliers, but it’s peripheral to Lam’s core demand drivers. This Toilet Stock Is Surging as an AI Bet. An Activist Sees More Gains.
• Neutral Sentiment: Two short-interest data entries in the feed show zero or inconsistent values (0 shares / NaN), which appears to be a reporting/data issue rather than a meaningful change in betting against the stock. Monitor reliable short-interest releases for any real pressure.
• Neutral Sentiment: Articles discussing the evolving Lam narrative compile the above themes (upgraded targets, expansion, AI cycle) — useful context but largely reiterative rather than new catalysts. How The Narrative Around Lam Research (LRCX) Is Evolving With New Forecasts And Expansion Moves

Lam Research Stock Performance

NASDAQ LRCX opened at $244.92 on Friday. The business’s 50 day moving average price is $209.11 and its 200-day moving average price is $160.75. Lam Research has a fifty-two week low of $56.32 and a fifty-two week high of $251.87. The company has a market cap of $305.85 billion, a P/E ratio of 50.19, a P/E/G ratio of 2.63 and a beta of 1.78. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.61 and a current ratio of 2.26.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.10. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The company had revenue of $5.34 billion during the quarter, compared to the consensus estimate of $5.23 billion. During the same period last year, the company earned $0.91 earnings per share. Lam Research’s revenue was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Sell-side analysts predict that Lam Research will post 3.71 earnings per share for the current year.

Lam Research Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be paid a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend is Wednesday, March 4th. Lam Research’s payout ratio is currently 21.31%.

Insider Activity

In related news, Director Eric Brandt sold 35,000 shares of the business’s stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the completion of the sale, the director owned 253,705 shares in the company, valued at approximately $57,235,848. The trade was a 12.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.31% of the company’s stock.

Hedge Funds Weigh In On Lam Research

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. PMV Capital Advisers LLC purchased a new stake in Lam Research in the fourth quarter worth about $25,000. Stance Capital LLC purchased a new stake in shares of Lam Research in the 3rd quarter worth approximately $26,000. Howard Hughes Medical Institute purchased a new stake in shares of Lam Research in the 2nd quarter worth approximately $27,000. Triumph Capital Management bought a new position in shares of Lam Research during the third quarter valued at approximately $27,000. Finally, Mcguire Capital Advisors Inc. purchased a new position in Lam Research during the fourth quarter valued at approximately $27,000. Institutional investors own 84.61% of the company’s stock.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.